PROQR THERAPEUTICS NV
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About PRQR
ProQR Therapeutics N.V. is a pre-clinical stage biopharmaceutical company based in the Netherlands. The Company is engaged in the discovery and development of ribonucleic Acid (RNA)-based therapeutics for the treatment of severe genetic disorders. It designs its therapeutic candidates to specifically target and repair the defective messenger RNA, or Messenger Ribonucleic Acid (mRNA), that is transcribed from a mutated gene in order to restore the expression and function of normal, or wild-type protein. Its product candidates include QR-010, an RNA-based oligonucleotide for the treatment of cystic fibrosis (CF), QR-110, an oligonucleotide and for the treatment of Leber’s congenital amaurosis (LCA).
Find out what a historical investment in PROQR THERAPEUTICS NV would be worth today using our PRQR stock calculator.
$197.80M
-
0.00%
0
$1.92
$1.88
$0.00
$4.62
$1.07
Ready to start your investing journey with Stake?
Open an accountPRQR FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in PRQR
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in PRQR
on Stake
Buy PRQR from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of PRQR from only US$10 with fractional shares
